Rakuten Medical

Rakuten Medical is a global biotechnology company dedicated to conquering cancer. Founded in 2010, the company is committed to developing and commercializing innovative cancer treatments based on its proprietary Alluminox™ platform, which utilizes photoimmunotherapy. The platform combines a drug component, selectively targeting cancer cells, with a device component that illuminates these cells with light to activate the drug, leading to rapid and selective cell destruction.

Rakuten Medical is focused on bringing its treatments to market as quickly as possible. The company has secured conditional approval in Japan for its first drug, ASP-1929, for the treatment of head and neck cancer, and is currently conducting global Phase 3 clinical trials to further expand its reach. Additionally, Rakuten Medical has established a strong presence in Asia, specifically Japan, where its Alluminox treatment has seen commercial success. The company is actively pursuing FDA approval for ASP-1929 and exploring partnerships to bring its innovative therapies to patients worldwide.

Rakuten Medical offers flexible Paid Time Off, suggesting a degree of autonomy over scheduling. While specific details regarding remote work or hybrid arrangements are not mentioned, the company emphasizes its commitment to building a "company unlike any other biotechnology entity" hinting at potentially progressive work practices.

Rakuten Medical offers a competitive benefits package including comprehensive health, vision and dental insurance, life insurance, flexible paid time off, stock options, and a 401k plan.

Rakuten Medical is a global biotechnology company dedicated to conquering cancer. They aim to achieve this by developing and commercializing innovative cancer treatments based on their proprietary Alluminox™ platform, a technology combining investigational drugs and devices. Rakuten Medical's vision is to build a sustainable healthcare ecosystem that provides patients with access to better cancer treatments, regardless of their nationality or wealth, through continued innovation and the commercialization of pioneering cancer treatments.

Rakuten Medical promotes a culture of collaboration, transparency, and hard work, emphasizing innovation and a dedication to patients. They aim to create a unique environment that fosters teamwork, encourages open communication, and values ambitious efforts in the pursuit of groundbreaking cancer treatments.

Rakuten Medical is committed to building a diverse, equitable, and inclusive workplace that reflects the global population they aim to serve. They prioritize empowerment by fostering an environment of collaboration, transparency, and hard work, while upholding ethical standards and a culture of trust. This commitment is further evidenced by their efforts to hire individuals from a variety of backgrounds and to provide equal opportunities for advancement.